Idexx Laboratories (IDXX) 111.83 $IDXX Ride the
Post# of 273333
Posted On: 09/21/2016 1:06:10 AM
Idexx Laboratories (IDXX) 111.83 $IDXX
Ride the Momentum with These 4 Fast-Moving Stocks
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:48AM CDT
This screen will help you to get into momentum stocks that are storming ahead. Highlighted stocks include HL, UFPI, IDXX and MTZ.
HL: 5.67 (+0.08), IDXX: 111.83 (+1.19), UFPI: 100.43 (+0.16), MTZ: 27.53 (-1.00)
LeMaitre Hits 52-Week High on Strong International Presence
Zacks Equity Research - Zacks Investment Research - Wed Sep 14, 7:49AM CDT
Share price of Burlington, MA-based LeMaitre Vascular, Inc. (LMAT) reached a new 52-week high of $21.20 on Sep 13, eventually closing a bit lower at $20.39.
MASI: 59.31 (-0.53), LMAT: 21.78 (+0.06), LNTH: 8.50 (+0.05), IDXX: 111.83 (+1.19)
Shares of IDXX Up 52.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Sep 13, 2:19PM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 7 months, Idexx Laboratories has returned 52.58% as of today's recent price of $109.51.
IDXX: 111.83 (+1.19)
Acadia & Ochsner Form Partnership, Announce New Facility
Zacks Equity Research - Zacks Investment Research - Tue Sep 13, 7:33AM CDT
Acadia Healthcare (ACHC) recently announced a strategic partnership with Ochsner Health System to set up an 82-bed acute psychiatric hospital, scheduled to open in 2018.
ACHC: 50.20 (-0.83), MASI: 59.31 (-0.53), IDXX: 111.83 (+1.19), NUVA: 66.89 (+0.36)
Varian (VAR) Acquires Radiotherapy Business of Candela
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 10:01AM CDT
Varian Medical Systems (VAR) recently announced the acquisition of the radiotherapy business of Candela.
MASI: 59.31 (-0.53), VAR: 96.01 (-0.04), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)
STERIS Poised on Synergy Health Addition amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Thu Sep 08, 8:18AM CDT
On Sep 8, we issued an updated research report on OH-based STERIS plc (STE).
MASI: 59.31 (-0.53), STE: 72.82 (+1.07), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)
Cepheid (CPHD) Gets FDA Clearance for Xpert TV Assay
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 9:23AM CDT
Cepheid (CPHD) recently received an approval for its Xpert TV assay from the U.S. FDA.
MASI: 59.31 (-0.53), CPHD: 52.49 (-0.07), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)
Ensign Group (ENSG) Acquires Kinder Hearts, Grows in Texas
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 9:15AM CDT
The Ensign Group, Inc. (ENSG) recently announced that Cornerstone Healthcare, its home health and hospice portfolio subsidiary, has acquired Abilene, TX-based Kinder Hearts Home Health and Hospice.
ENSG: 20.95 (-0.05), MASI: 59.31 (-0.53), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)
IDEXX Laboratories to Present at Raymond James North American Equities Conference
PR Newswire - Tue Sep 06, 1:01PM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the Raymond James 12th Annual North American Equities Conference. Michael Williams, PhD, Executive Vice President, is scheduled to make a presentation on the Company on Tuesday, September 13, 2016 at 12:45 p.m. BST/7:45 a.m. EDT, at the Four Seasons Hotel London at Park Lane, London, England. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archive of the presentation will be available via the same link.
IDXX: 111.83 (+1.19)
Uptrend Call Working As Idexx Laboratories Stock Rises 59.0% (IDXX)
Comtex SmarTrend(R) - Tue Sep 06, 12:20AM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 7 months, Idexx Laboratories has returned 58.97% as of today's recent price of $114.09.
IDXX: 111.83 (+1.19)
Globus Medical (GMED) Closes Alphatec Buyout, Stock Gains
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 8:18AM CDT
Globus Medical, Inc. (GMED) recently completed the acquisition of Alphatec Holdings, which was announced earlier in July.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), GMED: 22.21 (-0.16), IDXX: 111.83 (+1.19)
St. Jude Medical (STJ) Launches Trial for Amulet Occluder
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:54AM CDT
St. Jude Medical, Inc. (STJ), a global medical device company, announced that it has initiated a trial for its AMPLATZER Amulet occlude.
MASI: 59.31 (-0.53), QDEL: 22.91 (+0.60), STJ: 78.89 (-0.15), IDXX: 111.83 (+1.19)
The Cooper Companies (COO) Beats Q3 Earnings, View Up
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:27AM CDT
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.30 in the third quarter of 2016, beating the Zacks Consensus Estimate by 2 cents and improving 16.8% on a year-over-year basis.
BABY: 43.20 (+0.24), QDEL: 22.91 (+0.60), IDXX: 111.83 (+1.19), COO: 186.41 (-2.06)
FEI Shareholders Approve Thermo Fisher Deal (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 4:44PM CDT
Shareholders of FEI recently approved mega $4.2 billion deal to be acquired by Thermo Fisher Scientific.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), TMO: 151.62 (+1.62), IDXX: 111.83 (+1.19)
Thermo Fisher Shareholders Approve FEI Deal, Grows in Electron Microscopy (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 2:59PM CDT
Shareholders of Thermo Fisher recently approved its previously announced mega $4.2 billion acquisition of FEI Company.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), TMO: 151.62 (+1.62), IDXX: 111.83 (+1.19)
Henry Schein to Buy Marrodent Stake, Expand in Poland
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 8:48AM CDT
Keeping in line with its strategy of growth through rapid expansion internationally, Henry Schein Inc (HSIC) has agreed to acquire 80% ownership of Marrodent.
MASI: 59.31 (-0.53), QDEL: 22.91 (+0.60), IDXX: 111.83 (+1.19), HSIC: 162.80 (+0.32)
Thermo Fisher Closes FEI Deal, Grows in Electron Microscopy
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 6:42AM CDT
Thermo Fisher Scientific, Inc. (TMO) recently completed its earlier announced mega $4.2 billion acquisition of FEI Company.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), TMO: 151.62 (+1.62), IDXX: 111.83 (+1.19)
Why IDEXX Laboratories (IDXX) is Poised to Beat Earnings Estimates (Again)
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:08AM CDT
IDEXX Laboratories (IDXX) has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
IDXX: 111.83 (+1.19)
Varian Medical Excels on Growing International Footprint
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:46AM CDT
Varian recently announced the installation of a Clinac iX medical linear accelerator at Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia.
MASI: 59.31 (-0.53), VAR: 96.01 (-0.04), QDEL: 22.91 (+0.60), IDXX: 111.83 (+1.19)
Ride the Momentum with These 4 Fast-Moving Stocks
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:48AM CDT
This screen will help you to get into momentum stocks that are storming ahead. Highlighted stocks include HL, UFPI, IDXX and MTZ.
HL: 5.67 (+0.08), IDXX: 111.83 (+1.19), UFPI: 100.43 (+0.16), MTZ: 27.53 (-1.00)
LeMaitre Hits 52-Week High on Strong International Presence
Zacks Equity Research - Zacks Investment Research - Wed Sep 14, 7:49AM CDT
Share price of Burlington, MA-based LeMaitre Vascular, Inc. (LMAT) reached a new 52-week high of $21.20 on Sep 13, eventually closing a bit lower at $20.39.
MASI: 59.31 (-0.53), LMAT: 21.78 (+0.06), LNTH: 8.50 (+0.05), IDXX: 111.83 (+1.19)
Shares of IDXX Up 52.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Sep 13, 2:19PM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 7 months, Idexx Laboratories has returned 52.58% as of today's recent price of $109.51.
IDXX: 111.83 (+1.19)
Acadia & Ochsner Form Partnership, Announce New Facility
Zacks Equity Research - Zacks Investment Research - Tue Sep 13, 7:33AM CDT
Acadia Healthcare (ACHC) recently announced a strategic partnership with Ochsner Health System to set up an 82-bed acute psychiatric hospital, scheduled to open in 2018.
ACHC: 50.20 (-0.83), MASI: 59.31 (-0.53), IDXX: 111.83 (+1.19), NUVA: 66.89 (+0.36)
Varian (VAR) Acquires Radiotherapy Business of Candela
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 10:01AM CDT
Varian Medical Systems (VAR) recently announced the acquisition of the radiotherapy business of Candela.
MASI: 59.31 (-0.53), VAR: 96.01 (-0.04), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)
STERIS Poised on Synergy Health Addition amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Thu Sep 08, 8:18AM CDT
On Sep 8, we issued an updated research report on OH-based STERIS plc (STE).
MASI: 59.31 (-0.53), STE: 72.82 (+1.07), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)
Cepheid (CPHD) Gets FDA Clearance for Xpert TV Assay
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 9:23AM CDT
Cepheid (CPHD) recently received an approval for its Xpert TV assay from the U.S. FDA.
MASI: 59.31 (-0.53), CPHD: 52.49 (-0.07), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)
Ensign Group (ENSG) Acquires Kinder Hearts, Grows in Texas
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 9:15AM CDT
The Ensign Group, Inc. (ENSG) recently announced that Cornerstone Healthcare, its home health and hospice portfolio subsidiary, has acquired Abilene, TX-based Kinder Hearts Home Health and Hospice.
ENSG: 20.95 (-0.05), MASI: 59.31 (-0.53), IDXX: 111.83 (+1.19), CRY: 17.86 (unch)
IDEXX Laboratories to Present at Raymond James North American Equities Conference
PR Newswire - Tue Sep 06, 1:01PM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the Raymond James 12th Annual North American Equities Conference. Michael Williams, PhD, Executive Vice President, is scheduled to make a presentation on the Company on Tuesday, September 13, 2016 at 12:45 p.m. BST/7:45 a.m. EDT, at the Four Seasons Hotel London at Park Lane, London, England. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archive of the presentation will be available via the same link.
IDXX: 111.83 (+1.19)
Uptrend Call Working As Idexx Laboratories Stock Rises 59.0% (IDXX)
Comtex SmarTrend(R) - Tue Sep 06, 12:20AM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 7 months, Idexx Laboratories has returned 58.97% as of today's recent price of $114.09.
IDXX: 111.83 (+1.19)
Globus Medical (GMED) Closes Alphatec Buyout, Stock Gains
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 8:18AM CDT
Globus Medical, Inc. (GMED) recently completed the acquisition of Alphatec Holdings, which was announced earlier in July.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), GMED: 22.21 (-0.16), IDXX: 111.83 (+1.19)
St. Jude Medical (STJ) Launches Trial for Amulet Occluder
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:54AM CDT
St. Jude Medical, Inc. (STJ), a global medical device company, announced that it has initiated a trial for its AMPLATZER Amulet occlude.
MASI: 59.31 (-0.53), QDEL: 22.91 (+0.60), STJ: 78.89 (-0.15), IDXX: 111.83 (+1.19)
The Cooper Companies (COO) Beats Q3 Earnings, View Up
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:27AM CDT
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.30 in the third quarter of 2016, beating the Zacks Consensus Estimate by 2 cents and improving 16.8% on a year-over-year basis.
BABY: 43.20 (+0.24), QDEL: 22.91 (+0.60), IDXX: 111.83 (+1.19), COO: 186.41 (-2.06)
FEI Shareholders Approve Thermo Fisher Deal (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 4:44PM CDT
Shareholders of FEI recently approved mega $4.2 billion deal to be acquired by Thermo Fisher Scientific.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), TMO: 151.62 (+1.62), IDXX: 111.83 (+1.19)
Thermo Fisher Shareholders Approve FEI Deal, Grows in Electron Microscopy (Revised)
Urmimala Biswas - Zacks Investment Research - Thu Sep 01, 2:59PM CDT
Shareholders of Thermo Fisher recently approved its previously announced mega $4.2 billion acquisition of FEI Company.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), TMO: 151.62 (+1.62), IDXX: 111.83 (+1.19)
Henry Schein to Buy Marrodent Stake, Expand in Poland
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 8:48AM CDT
Keeping in line with its strategy of growth through rapid expansion internationally, Henry Schein Inc (HSIC) has agreed to acquire 80% ownership of Marrodent.
MASI: 59.31 (-0.53), QDEL: 22.91 (+0.60), IDXX: 111.83 (+1.19), HSIC: 162.80 (+0.32)
Thermo Fisher Closes FEI Deal, Grows in Electron Microscopy
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 6:42AM CDT
Thermo Fisher Scientific, Inc. (TMO) recently completed its earlier announced mega $4.2 billion acquisition of FEI Company.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), TMO: 151.62 (+1.62), IDXX: 111.83 (+1.19)
Why IDEXX Laboratories (IDXX) is Poised to Beat Earnings Estimates (Again)
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:08AM CDT
IDEXX Laboratories (IDXX) has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
IDXX: 111.83 (+1.19)
Varian Medical Excels on Growing International Footprint
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:46AM CDT
Varian recently announced the installation of a Clinac iX medical linear accelerator at Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia.
MASI: 59.31 (-0.53), VAR: 96.01 (-0.04), QDEL: 22.91 (+0.60), IDXX: 111.83 (+1.19)
(0)
(0)